Matritech, Boehringer Ingelheim International GmbH, Wallac ADL GmbH deal

NMPS and Boehringer Ingelheim terminated their 1994 agreement for the German distribution of NMPS's Matritech NMP22 Test Kit for bladder cancer. NMPS said the pharma company's priorities had changed. Wallac, which has replaced Boehringer Ingelheim, will distribute NMP22 on a non-exclusive basis in Germany. ...